News

Each investment unit consists of a share of common stock, two series of common stock purchase warrants to purchase 0.5 share of common stock respectively. Approximately $2.5 million

Bentley stockholders will receive from Teva a final per-share purchase price of approximately $14.82 in cash in exchange for their Bentley common stock if the merger agreement is

The $3 million grant will fund efforts to further develop Antigen Discovery’s (ADI) protein microarray based serodiagnostic platform for applications in biodefense and emerging infectious diseases. ADI will

Senesco has previously reported positive preclinical in vivo results using its combination siRNA and plasmid against subcutaneous multiple myeloma tumors in immunodeficient mice. Bruce Galton, president and CEO

The company currently markets Granisetron in 0.1mg/ml, 1ml single dose vials and will commence distributing the 1mg/ml, 1ml single dose, and 1mg/ml, 4ml multiple dose vials immediately. All

This follows the resignation of William Pinon as the company’s president and CEO and as a member of the board of directors as of the same date. Mr

Senesco has previously reported positive preclinical in vivo results using its combination siRNA and plasmid delivered with ‘in vivo-jetPEI’ against subcutaneous multiple myeloma tumors in immunodeficient mice. Bruce

Under the terms of the five-year agreement, Akorn will be responsible for the manufacturing and supply of the two injectable products. Expected launch for both products is anticipated

Pursuant to the agreement, Regeneron will make an up-front payment to Cellectis in the amount of $12.45 million. In addition, Regeneron will pay Cellectis a low single-digit royalty